Casdin Capital as of Sept. 30, 2019
Portfolio Holdings for Casdin Capital
Casdin Capital holds 33 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spark Therapeutics | 8.7 | $84M | 863k | 96.98 | |
| Invitae (NVTAQ) | 7.7 | $74M | 3.8M | 19.27 | |
| Codexis (CDXS) | 7.2 | $70M | 5.1M | 13.71 | |
| Blueprint Medicines (BPMC) | 7.2 | $69M | 940k | 73.47 | |
| Sarepta Therapeutics (SRPT) | 6.9 | $66M | 880k | 75.32 | |
| Myokardia | 6.0 | $58M | 1.1M | 52.15 | |
| Bluebird Bio (BLUE) | 5.8 | $56M | 613k | 91.82 | |
| Sage Therapeutics (SAGE) | 5.8 | $56M | 400k | 140.29 | |
| Alnylam Pharmaceuticals (ALNY) | 5.0 | $48M | 600k | 80.42 | |
| Biolife Solutions (BLFS) | 4.2 | $40M | 2.4M | 16.62 | |
| Fate Therapeutics (FATE) | 4.1 | $40M | 2.6M | 15.53 | |
| Magenta Therapeutics | 3.2 | $31M | 3.0M | 10.26 | |
| Agios Pharmaceuticals (AGIO) | 3.1 | $30M | 935k | 32.40 | |
| Audentes Therapeutics | 2.5 | $24M | 860k | 28.09 | |
| Caredx (CDNA) | 2.3 | $23M | 1.0M | 22.61 | |
| GenMark Diagnostics | 2.1 | $20M | 3.4M | 6.06 | |
| Voyager Therapeutics (VYGR) | 2.0 | $19M | 1.1M | 17.21 | |
| Illumina (ILMN) | 1.9 | $18M | 60k | 304.22 | |
| Gritstone Oncology Ord (GRTSQ) | 1.6 | $15M | 1.8M | 8.63 | |
| Homology Medicines | 1.5 | $15M | 820k | 18.10 | |
| Global Blood Therapeutics In | 1.5 | $15M | 300k | 48.52 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.5 | $14M | 463k | 30.90 | |
| Sangamo Biosciences (SGMO) | 1.4 | $13M | 1.5M | 9.05 | |
| Alector (ALEC) | 1.2 | $12M | 811k | 14.42 | |
| Denali Therapeutics (DNLI) | 1.0 | $10M | 650k | 15.32 | |
| Constellation Pharmceticls I | 1.0 | $9.8M | 1.5M | 6.46 | |
| Editas Medicine (EDIT) | 1.0 | $9.4M | 415k | 22.74 | |
| Twist Bioscience Corp (TWST) | 0.7 | $7.2M | 300k | 23.88 | |
| Fulcrum Therapeutics (FULC) | 0.6 | $5.6M | 844k | 6.64 | |
| Orchard Therapeutics Plc ads | 0.4 | $3.7M | 310k | 11.88 | |
| Deciphera Pharmaceuticals | 0.3 | $3.4M | 100k | 33.94 | |
| Turning Point Therapeutics I | 0.3 | $2.8M | 75k | 37.60 | |
| Stoke Therapeutics (STOK) | 0.3 | $2.8M | 130k | 21.49 |
